These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2340315)

  • 21. Isolation and characterization of the third and fifth components of rabbit complement.
    Giclas PC; Keeling PJ; Henson PM
    Mol Immunol; 1981 Feb; 18(2):113-23. PubMed ID: 7266481
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
    Strunk RC; Giclas PC
    J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation and identification of the third component of complement of Japanese quails.
    Kai C; Yoshikawa Y; Yamanouchi K; Okada H
    J Immunol; 1983 Jun; 130(6):2814-20. PubMed ID: 6343485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of the third component of rat complement.
    Daha MR; Stuffers-Heiman M; Kijlstra A; van Es LA
    Immunology; 1979 Jan; 36(1):63-70. PubMed ID: 422228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separation of six bovine complement components and one inactivator (1, 2).
    Barta O; Nelson RA; Kuo CY
    Immunol Commun; 1976; 5(1-2):75-86. PubMed ID: 950248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of the third and fifth components of human complement: application of hydrophobic chromatography.
    Kunkel SL; Kreutzer DL; Goralnick S; Ward PA
    J Immunol Methods; 1980; 35(3-4):337-51. PubMed ID: 7400588
    [No Abstract]   [Full Text] [Related]  

  • 27. Fifth component of guinea pig complement: purification and characterization.
    Kinoshita T; Hong K; Kondo K; Inoue K
    J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complement system in hemolytic-uremic syndrome in childhood.
    Monnens L; Molenaar J; Lambert PH; Proesmans W; van Munster P
    Clin Nephrol; 1980 Apr; 13(4):168-71. PubMed ID: 7379368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.
    Nicholson-Weller A; Burge J; Austen KF
    J Immunol; 1981 Nov; 127(5):2035-9. PubMed ID: 6913607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of human complement component C3 from small volumes of plasma.
    Gresham HD; Matthews DF; Griffin FM
    Anal Biochem; 1986 May; 154(2):454-9. PubMed ID: 3524310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative determination of complement components produced by purified hepatocytes.
    Ramadori G; Rasokat H; Burger R; Meyer Zum Büschenfelde KH; Bitter-Suermann D
    Clin Exp Immunol; 1984 Jan; 55(1):189-96. PubMed ID: 6692595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement localization in ischemic baboon myocardium.
    McManus LM; Kolb WP; Crawford MH; O'Rourke RA; Grover FL; Pinckard RN
    Lab Invest; 1983 Apr; 48(4):436-47. PubMed ID: 6339810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
    Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
    Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.
    Ruseva MM; Hughes TR; Donev RM; Sivasankar B; Pickering MC; Wu X; Harris CL; Morgan BP
    Mol Immunol; 2009 Feb; 46(5):803-11. PubMed ID: 18947875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria.
    Lackner P; Hametner C; Beer R; Burger C; Broessner G; Helbok R; Speth C; Schmutzhard E
    Malar J; 2008 Oct; 7():207. PubMed ID: 18847493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and purification of C3 from human plasma.
    O'Rear LD; Ross GD
    Curr Protoc Immunol; 2001 May; Chapter 13():13.3.1-13.3.16. PubMed ID: 18432716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
    Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW
    Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.